The impact of training set data distributions for modelling of passive intestinal absorption

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 711-720

  Ghafourian, Taravat ^a,b   Freitas, Alex A ^c   Newby, Danielle ^a  

^a MEDWAY SCHOOL OF PHARMACY   (United Kingdom)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Classification; Intestinal absorption; Oral absorption; QSAR; Regression; Training set

Indexed keywords

ARTICLE; COMPARATIVE STUDY; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG INDUSTRY; HUMAN; INTESTINE ABSORPTION; MEDICAL LITERATURE; PRIORITY JOURNAL; REGRESSION ANALYSIS;

HUMANS; INTESTINAL ABSORPTION; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PHARMACEUTICAL PREPARATIONS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 84865293406     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.07.041     Document Type: Article

References (63)

1. Q. Al-Awqati One hundred years of membrane permeability: does Overton still rule? Nat. Cell. Biol. 1 1999 E201 E202
2. M. Ashford Part 4: Biopharmaceutical principles of drug delivery M.E. Aulton, Aulton's Pharmaceutics, The Design and Manufacture of Medicines third ed. 2007 Churchill Livingstone Elsevier Philadelphia 265 324
3. A.P. Beresford, M. Segall, and M.H. Tarbit In silico prediction of ADME properties: are we making progress? Curr. Opin. Drug. Discov. Devel. 7 2004 36 42
4. A. Boobis, U. Gundert-Remy, P. Kremers, P. Macheras, and O. Pelkonen In silico prediction of ADME and pharmacokinetics - report of an expert meeting organised by COST B15 Eur. J. Pharm. Sci. 17 2002 183 193
5. P.S. Burton, J.T. Goodwin, T.J. Vidmar, and B.M. Amore Predicting drug absorption: how nature made it a difficult problem J. Pharmacol. Exp. Ther. 303 2002 889 895
6. D.E. Clark Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena prediction of intestinal absorption J. Pharm. Sci. 88 1999 807 814
7. D.E. Clark What has polar surface area ever done for drug discovery? Future Med. Chem. 3 2011 469 484
8. J.E.A. Comer High-throughput measurement of logD and pka H.v.d. Waterbeemd, H. Lennernäs, P. Artursson, R. Mannhold, H. Kubinyi, G. Folkers, Drug Bioavailability: Estimation of Solubility, Permeability Absorption and Bioavailability (Methods and Principles in Medicinal Chemistry) first ed. 2003 Wiley-VCH Weinheim p. 23
9. D. Cummings Pharmaceutical drug discovery: designing the blockbuster drug A. Dean, S. Lewis, Screening Methods for Experimentation in Industry, Drug Discovery, and Genetics first ed. 2006 Springer NY 74 76
10. A.M. Davis, and P. Brunea Silico prediction of solubility H.v.d. Waterbeemd, H. Lennernäs, P. Artursson, R. Mannhold, H. Kubinyi, G. Folkers, Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability (Methods and Principles in Medicinal Chemistry) first ed. 2003 Wiley-VCH Weinheim 53 56
11. A.M. Davis, D.J. Keeling, J. Steele, N.P. Tomkinson, and A.C. Tinker Components of successful lead generation Curr. Top. Med. Chem. 5 2005 421 439
12. W.J. Egan, K.M. Merz, and J.J. Baldwin Prediction of drug absorption using multivariate statistics J. Med. Chem. 43 2000 3867 3877
13. T. Geerts, and Y.V. Heyden In silico predictions of ADME-Tox properties: drug absorption Comb. Chem. High. Throughput Screening 14 2011 339 361
14. K.M. Giacomini, S.M. Huang, D.J. Tweedie, L.Z. Benet, K.L.R. Brouwer, X.Y. Chu, A. Dahlin, R. Evers, V. Fischer, K.M. Hillgren, K.A. Hoffmaster, T. Ishikawa, D. Keppler, R.B. Kim, C.A. Lee, M. Niemi, J.W. Polli, Y. Sugiyama, P.W. Swaan, J.A. Ware, S.H. Wright, S.W. Yee, M.J. Zamek-Gliszczynski, L. Zhang, and T. International Membrane transporters in drug development Nat. Rev. Drug Discov. 9 2010 215 236
15. M.P. Gleeson, A. Hersey, and S. Hannongbua In silico ADME models: a general assessment of their utility in drug discovery applications Curr. Top. Med. Chem. 11 2011 358 381
16. T.J. Hou, Y.Y. Li, W. Zhang, and J.M. Wang Recent developments of in silico predictions of intestinal absorption and oral bioavailability Comb. Chem. High. Throughput Screening 12 2009 497 506
17. T.J. Hou, J.M. Wang, and Y.Y. Li ADME evaluation in drug discovery 8. The prediction of human intestinal absorption by a support vector machine J. Chem. Inf. Model. 47 2007 2408 2415
18. T.J. Hou, J.M. Wang, W. Zhang, W. Wang, and X. Xu Recent advances in computational prediction of drug absorption and permeability in drug discovery Current Medicinal Chemistry 13 2006 2653 2667
19. T.J. Hou, J.M. Wang, W. Zhang, and X.J. Xu ADME evaluation in drug discovery 6. Can oral bioavailability in humans be effectively predicted by simple molecular property-based rules? J. Chem. Inf. Model. 47 2007 460 463
20. T.J. Hou, J.M. Wang, W. Zhang, and X.J. Xu ADME evaluation in drug discovery 7. Prediction of oral absorption by correlation and classification J. Chem. Inf. Model. 47 2007 208 218
21. K. Kay K. Tsaioun, S.A. Kates, Introduction. ADMET for Medicinal Chemists A Practical Guide 2011 Wiley NJ 10 11
22. R.W. Kennard, and L.A. Stone Computer aided design of experiments Technometrics 11 1969 137 148
23. T. Kennedy Managing the drug discovery/development interface Drug Discov. Today 2 1997 436 444
24. E.H. Kerns, and L. Di Drug Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimisation first ed. 2008 Academic Press Elsevier Burlington
25. G. Klopman, L.R. Stefan, and R.D. Saiakhov ADME evaluation 2. A computer model for the prediction of intestinal absorption in humans European Journal of Pharmaceutical Sciences 17 2002 253 263
26. I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3 2004 711 715
27. S. Kortagere, and S. Ekins Troubleshooting computational methods in drug discovery J. Pharmacol. Toxicol. Methods 61 2010 67 75
28. Y. Kwon Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists first ed. 2002 Springer NY
29. D. Lagorce, C. Reynes, A.C. Camproux, M.A. Mitieva, O. Sperandio, and B.O. Villoutreix In silico admet/tox predictions K. Tsaioun, S.A. Kates, ADMET for Medicinal Chemists A Practical Guide 2011 Wiley 29 123
30. C.A. Lipinski, F. Lombardo, B.W. Dominy, and P.J. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25
31. P. Macheras, and A. Iliadis Modeling in Biopharmaceutics, Pharmacokinetics and Pharmacodynamics - Homogenous and Heterogenous Approaches 2006 Springer NY
32. N. Malo, J.A. Hanley, S. Cerquozzi, J. Pelletier, and R. Nadon Statistical practice in high-throughput screening data analysis Nat. Biotechnol. 24 2006 167 175
33. M.N. Martinez, and G.L. Amidon A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals J. Clin. Pharmacol. 42 2002 620 643
34. J.M. Miller, A. Dahan, D. Gupta, S. Varghese, and G.L. Amidon Enabling the intestinal absorption of highly polar antiviral agents: ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir Mol. Pharm. 7 2010 1223 1234
35. T. Niwa Using general regression and probabilistic neural networks to predict human intestinal absorption with topological descriptors derived from two-dimensional chemical structures J. Chem. Inf. Comput. Sci. 43 2003 113 119
36. U. Norinder, T. Osterberg, and P. Artursson Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics Pharm. Res. 14 1997 1786 1791
37. T.I. Oprea Property distribution of drug-related chemical databases J. Comput. Aided Mol. Des. 14 2000 251 264
38. T.I. Oprea, T.K. Allu, D.C. Fara, R.F. Rad, L. Ostopovici, and C.G. Bologa Lead-like, drug-like or pub-like: how different are they? J. Comput. Aided Mol. Des. 21 2007 113 119
39. K. Palm, K. Luthman, A.L. Ungell, G. Strandlund, and P. Artursson Correlation of drug absorption with molecular surface properties J. Pharm. Sci. 85 1996 32 39
40. K. Palm, P. Stenberg, K. Luthman, and P. Artursson Polar molecular surface properties predict the intestinal absorption of drugs in humans Pharm. Res. 14 1997 568 571
41. D.P. Reynolds, K. Lanevskij, P. Japertas, R. Didziapetris, and A. Petrauskas Ionization-specific analysis of human intestinal absorption J. Pharm. Sci. 98 2009 4039 4054
42. P.J. Sinko Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches Curr. Opin. Drug Discov. Dev. 2 1999 42 48
43. D.A. Smith Hello drug discovery, I am from Insilico, take me to your President Drug Discov. Today 7 2002 1080 1081
44. P. Stenberg, K. Luthman, and P. Artursson Virtual screening of intestinal drug permeability J. Control. Release 65 2000 231 243
45. T.R. Stouch, J.R. Kenyon, S.R. Johnson, X.Q. Chen, A. Doweyko, and Y. Li In silico ADME/Tox: why models fail J. Comput. Aided Mol. Des. 17 2003 83 92
46. C. Suenderhauf, F. Hammann, A. Maunz, C. Helma, and J. Huwyler Combinatorial QSAR modeling of human intestinal absorption Mol. Pharm. 8 2011 213 224
47. K. Sugano, M. Kansy, P. Artursson, A. Avdeef, S. Bendels, L. Di, G.F. Ecker, B. Faller, H. Fischer, G. Gerebtzoff, H. Lennernaes, and F. Senner Coexistence of passive and carrier-mediated processes in drug transport Nat. Rev. Drug Discov. 9 2010 597 614
48. H.P. The, I. Gonzalez-Alvarez, M. Bermejo, V.M. Sanjuan, I. Centelles, T.M. Garrigues, and M.A. Cabrera-Perez In silico prediction of Caco-2 cell permeability by a classification QSAR approach Mol. Inform. 30 2011 376 385
49. S. Tian, Y. Li, J. Wang, J. Zhang, and T. Hou ADME evaluation in drug discovery 9. prediction of oral bioavailability in humans based on molecular properties and structural fingerprints Mol. Pharm. 8 2011 841 851
50. A. Tropsha Best practices for QSAR model development, validation, and exploitation Mol. Inform. 29 2010 476 488
51. K. Tsaioun, M. Bottlaender, and A. Mabondzo ADDME: avoiding drug development mistakes early: central nervous system drug discovery perspective BMC Neurol. 9 2009 S1
52. H. van de Waterbeemd, and E. Gifford ADMET in silico modelling: towards prediction paradise? Nat. Rev. Drug Discov. 2 2003 192 204
53. H. van de Waterbeemd, and M. Kansy Hydrogen-bonding capacity and brain penetration Chimia 46 1992 299 303
54. M.V.S. Varma, R.S. Obach, C. Rotter, H.R. Miller, G. Chang, S.J. Steyn, A. El-Kattan, and M.D. Troutman Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination J. Med. Chem. 53 2010 1098 1108
55. D.F. Veber, S.R. Johnson, H.Y. Cheng, B.R. Smith, K.W. Ward, and K.D. Kopple Molecular properties that influence the oral bioavailability of drug candidates J. Med. Chem. 45 2002 2615 2623
56. M.D. Wessel, P.C. Jurs, J.W. Tolan, and S.M. Muskal Prediction of human intestinal absorption of drug compounds from molecular structure J. Chem. Inf. Comp. Sci. 38 1998 726 735
57. Y. Xue, Z.R. Li, C.W. Yap, L.Z. Sun, X. Chen, and Y.Z. Chen Effect of molecular descriptor feature selection in support vector machine classification of pharmacokinetic and toxicological properties of chemical agents J. Chem. Inf. Comp. Sci. 44 2004 1630 1638
58. A. Yan, Z. Wang, and Z. Cai Prediction of human intestinal absorption by ga feature selection and support vector machine regression Int. J. Mol. Sci. 9 2008 1961 1976
59. P. Zakeri-Milani, H. Tajerzadeh, Z. Islambolchilar, S. Barzegar, and H. Valizadeh The relation between molecular properties of drugs and their transport across the intestinal membrane DARU 14 2006 164 171
60. J.H. Zhang, T.D.Y. Chung, and K.R. Oldenburg Confirmation of primary active substances from high throughput screening of chemical and biological populations: a statistical approach and practical considerations J. Comb. Chem. 2 2000 258 265
61. Y.H. Zhao, M.H. Abraham, J. Le, A. Hersey, C.N. Luscombe, G. Beck, B. Sherborne, and I. Cooper Rate-limited steps of human oral absorption and QSAR studies Pharm. Res. 19 2002 1446 1457
62. Y.H. Zhao, J. Le, M.H. Abraham, A. Hersey, P.J. Eddershaw, C.N. Luscombe, D. Boutina, G. Beck, B. Sherborne, I. Cooper, and J.A. Platts Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the abraham descriptors J. Pharm. Sci. 90 2001 749 784
63. J.Y. Zhu, J.M. Wang, H.D. Yu, Y.Y. Li, and T.J. Hou Recent developments of in silico predictions of oral bioavailability Comb. Chem. High. Throughput Screening 14 2011 362 374